Elysium Health Revenue and Competitors

Claim your profile

Location

$71.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elysium Health's estimated annual revenue is currently $13.2M per year.(i)
  • Elysium Health received $5.0M in venture funding in June 2017.
  • Elysium Health's estimated revenue per employee is $155,000
  • Elysium Health's total funding is $71.2M.

Employee Data

  • Elysium Health has 85 Employees.(i)
  • Elysium Health grew their employee count by 39% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$33.5M125-4%$81.7MN/A

Elysium Health's mission is to solve the biggest challenges in health with science, to help people live healthier for longer. Elysium works directly with top scientists, clinicians and health professionals around the world to translate advances in science and technology into innovative health products that work. Our product development pipeline begins with research and development, continues with preclinical studies, and culminates with human clinical trials to demonstrate the safety and efficacy of products. Throughout this process, Elysium's focus is to develop compounds found in nature that allow people to support their health proactively. Elysium is guided by a Scientific Advisory Board, which includes multiple winners of the Nobel Prize, as well as researchers and doctors who are experts in chemistry, physiology, neuroscience, complex chemical systems, biochemistry, and many other fields of study. Basis, Elysium Health's first product, is a proprietary formulation of two ingredients designed to support long-term health at the cellular level. Basis is clinically proven to increase NAD+ levels, which decline with age. NAD+ is required for energy creation, regulating circadian rhythms, maintaining healthy DNA, and hundreds of other biological functions.

keywords:Biotechnology,Fitness and Wellness,Food & Beverages,Healthcare,Pharmaceuticals

$71.2M

Total Funding

85

Number of Employees

$13.2M

Revenue (est)

39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elysium Health News

2022-04-19 - Ramsay Health confirms A$20bn bid from KKR-led consortium

A spokesperson told IPE Real Assets that the group leased all of its hospitals in the UK, but its subsidiary, Elysium Healthcare,...

2022-04-06 - Elysium Health™ Announces New Research Initiative in ...

The research collaboration expands on Elysium Health's ongoing partnership with the University of Oxford, which includes the Oxford-Elysium...

2022-03-22 - Elysium Health™ Announces Research Partnership with the ...

Elysium Health will seek to identify a whole brain health signal as well as brain health signals for specific regions. Accordingly, the company...

2020-12-15 - Elysium Health™ Announces Initiation of Phase II Clinical Trial at Mayo Clinic to Evaluate BASIS™ for Prevention of Acute Kidney Injury After Cardiac Surgery

NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Elysium Health, Inc.,TM a life sciences company developing clinically validated health products based on aging research, today announced the initiation of a Phase II clinical trial at Mayo Clinic to evaluate the efficacy of BASISTM for the prevention of ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.6M859%N/A
#2
N/A85102%N/A
#3
$15M85-3%N/A
#4
$17.9M85-3%N/A
#5
$8.5M85-29%N/A

Elysium Health Funding

DateAmountRoundLead InvestorsReference
2016-12-07$20.0MBGeneral CatalystArticle
2017-06-30$5.0MUndisclosedSilicon Valley BankArticle